Does emergent implantation of a vagal nerve stimulator stop refractory status epilepticus in children?

Area of Science:

• Neurology
• Epileptology
• Neurosurgery

Background:

• Status Epilepticus (SE) is a life-threatening neurological emergency in epilepsy patients.
• Refractory or super-refractory SE is defined by a lack of response to anti-epileptic and anesthetic drugs.
• Vagal Nerve Stimulation (VNS) is effective for drug-resistant epilepsy, but its use in emergent SE is less reported.

Purpose of the Study:

• To evaluate the efficacy of emergent Vagal Nerve Stimulation (VNS) in pediatric patients with refractory or super-refractory Status Epilepticus (SE).

Main Methods:

• Retrospective analysis of 4 children implanted with VNS for drug-resistant epilepsy.
• Identification of patients meeting criteria for refractory or super-refractory SE.
• Fast ramping-up of VNS output current to 1 mA over 24-36 hours.

Main Results:

• Three out of four pediatric patients experienced abrupt cessation of Status Epilepticus.
• One patient, refractory to both drugs and VNS, did not recover and died.
• Follow-up (24-45 months) showed >80% seizure frequency reduction in the remaining three patients without SE relapse.
• VNS output current and/or duty cycle were increased in all patients during follow-up.

Conclusions:

• Emergent Vagal Nerve Stimulation (VNS) can be an effective treatment for refractory or super-refractory Status Epilepticus in pediatric patients.
• VNS offers a potential therapeutic option for severe, drug-resistant SE cases.
• Long-term VNS therapy may lead to sustained seizure control and prevent SE recurrence.